Glaucoma Trial, Recruiting (NCT06057051)

Glaucoma Trial, Recruiting NCT06057051 Sponsor: Glaukos Corporation Condition: Glaucoma

Printed from Voxsanity (voxsanity.com.au) — NCT06057051 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Glaucoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a type of glaucoma called primary open-angle glaucoma
You have your natural lens in your eye, or you have had your natural lens replaced with an artificial one (for example, after cataract surgery)
You are 35 years old or older

Who may not be able to join:

You have a type of glaucoma caused by an injury, eye inflammation, abnormal blood vessel growth, or a closed drainage angle in the eye
You have glaucoma that is linked to problems with blood vessels
You currently have inflammation or swelling affecting your cornea (the clear front surface of your eye)
You have a condition affecting the retina (the light-sensitive layer at the back of your eye) that is not related to glaucoma

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 949-481-0575

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06057051

Sponsor: Glaukos Corporation

Phase: Not Applicable

Status: Recruiting

Condition: Glaucoma

Trial contact: 949-481-0575

More information: https://clinicaltrials.gov/study/NCT06057051

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a type of glaucoma called primary open-angle glaucoma
You have your natural lens in your eye, or you have had your natural lens replaced with an artificial one (for example, after cataract surgery)
You are 35 years old or older

Who may not be able to join:

You have a type of glaucoma caused by an injury, eye inflammation, abnormal blood vessel growth, or a closed drainage angle in the eye
You have glaucoma that is linked to problems with blood vessels
You currently have inflammation or swelling affecting your cornea (the clear front surface of your eye)
You have a condition affecting the retina (the light-sensitive layer at the back of your eye) that is not related to glaucoma

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Glaukos Corporation

Registry

ClinicalTrials.gov

Start date

1 September 2023

Est. completion

1 August 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean Diurnal Intraocular Pressure (IOP) 12-Month reduction ≥ 20% from Baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov